Clopidogrel and Dapsone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Dapsone (dapsone). Common drug interactions include quality of life decreased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Dapsone. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.



On May, 17, 2026

59 people who take Clopidogrel and Dapsone together, and have interactions are studied.

Clopidogrel and Dapsone drug interactions.

What are the common drug interactions of Clopidogrel and Dapsone, by gender? *:

female:

  1. Quality of life decreased
  2. Renal impairment (severely reduced kidney function)
  3. Abdominal distension
  4. Abdominal pain
  5. Abdominal pain upper
  6. Asthenia (weakness)
  7. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  8. Blood glucose increased
  9. Device related infection
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Dizziness
  4. Ageusia (loss of taste functions of the tongue)
  5. Balance disorder
  6. Blood creatinine increased
  7. Fatigue (feeling of tiredness)
  8. Flatulence (flatus expelled through the anus)
  9. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  10. Hepatic failure (liver failure)

What are the common drug interactions of Clopidogrel and Dapsone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Syncope (loss of consciousness with an inability to maintain postural tone)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Balance disorder
  6. Blood creatinine increased
  7. Chronic kidney disease
  8. Depression
  9. Emotional distress
  10. Fatigue (feeling of tiredness)

50-59:

  1. Pain in extremity
  2. Pruritus generalised (generalized itching)
  3. Renal failure (kidney dysfunction)
  4. Scab (a hard coating on the skin formed during the wound healing)
  5. Skin discolouration (change of skin colour)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Skin hyperpigmentation (disorders affect the colour of your skin)
  8. Skin hypertrophy (skin cells enlarges)
  9. Skin induration (an abnormally hard spot or area on the skin)
  10. Skin plaque (red, scaly patches to appear on the skin)

60+:

  1. Arthralgia (joint pain)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  4. Hepatic failure (liver failure)
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Lethargy (tiredness)
  7. Localised infection (infection at the single location)
  8. Mass
  9. Nausea (feeling of having an urge to vomit)
  10. Oropharyngeal pain

What are the existing conditions these people have? *

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 12 people, 20.34%
  2. Hiv Infection: 11 people, 18.64%
  3. High Blood Pressure: 11 people, 18.64%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 11.86%
  5. Pain: 7 people, 11.86%
  6. Gout (uric acid crystals building up in the body): 6 people, 10.17%
  7. Neuropathy Peripheral (surface nerve damage): 6 people, 10.17%
  8. Muscle Spasms (muscle contraction): 6 people, 10.17%
  9. High Blood Cholesterol: 5 people, 8.47%
  10. Type 2 Diabetes: 5 people, 8.47%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Dapsone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clopidogrel and Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopidogrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel and dapsone (the active ingredients of Clopidogrel and Dapsone, respectively), and Clopidogrel and Dapsone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: